State of La., Ex rel.charles C. Foti, Jr., Ag v. Janssen Pharmaceutica, Inc.
State of La., Ex rel.charles C. Foti, Jr., Ag v. Janssen Pharmaceutica, Inc., No. CW-0006-1148 (La. Ct. App. 3d Cir. Nov. 2, 2006).
Opinion text
NOT DESIGNATED FOR PUBLICATION
STATE OF LOUISIANA
COURT OF APPEAL, THIRD CIRCUIT
06-1148 consolidated with 06-1149
STATE OF LOUISIANA, EX REL. CHARLES C. FOTI, JR.,
ATTORNEY GENERAL
VERSUS
JANSSEN PHARMACEUTICA, INC., ET AL.
**********
APPEAL FROM THE
TWENTY-SEVENTH JUDICIAL DISTRICT COURT
PARISH OF ST. LANDRY, NOS. 04-C-3967 & 04-C-3977
HONORABLE DONALD W. HEBERT, DISTRICT JUDGE
**********
ELIZABETH A. PICKETT
JUDGE
**********
Court composed of Sylvia R. Cooks, Elizabeth A. Pickett, and James T. Genovese,
Judges.
MOTION TO DISMISS APPEAL
GRANTED. APPEAL CONVERTED
INTO APPLICATION FOR
SUPERVISORY WRIT.
Patrick C. Morrow
James P. Ryan
Jeffrey M. Bassett
Post Office Drawer 1787
324 W. Landry
Opelousas, LA 70570
(337) 948-4483
COUNSEL FOR PLAINTIFF/APPELLEE:
State of Louisiana, ex rel. Charles C. Foti, Jr., Attorney General
Kenneth W. DeJean
417 West University Avenue
Lafayette, LA 70502
(337) 235-5294
COUNSEL FOR PLAINTIFF/APPELLEE:
State of Louisiana, ex rel. Charles C. Foti, Jr., Attorney General
Robert L. Salim
1762 Texas Street
Natchitoches, LA 71467
(318) 352-5999
COUNSEL FOR PLAINTIFF/APPELLEE:
State of Louisiana, ex rel. Charles C. Foti, Jr., Attorney General
Kenneth T. Fibich
W. Michael Leebron
1401 McKinney, Suite 1800
Houston, TX 77010
(713) 751-0025
COUNSEL FOR PLAINTIFF/APPELLEE:
State of Louisiana, ex rel. Charles C. Foti, Jr., Attorney General
Michael W. Perrin
K. Camp Bailey
Bailey Perrin Bailey, LLP
440 Louisiana, Ste. 2100
Houston, TX 77002
(713) 425-7100
COUNSEL FOR PLAINTIFF/APPELLEE:
State of Louisiana, ex rel. Charles C. Foti, Jr., Attorney General
James B. Irwin
Monique Garsaud
Irwin, Fritchie, Urohart & Moore
400 Poydras Street, Suite 2700
New Orleans, LA 70130
(504) 310-2100
COUNSEL FOR DEFENDANT/APPELLANT:
Janssen Pharmaceutica, Inc.
Thomas Champion
Drinker, Biddle & Reath, LLP
500 Campus Drive
Florham Park, NJ 07932-1047
COUNSEL FOR DEFENDANT/APPELLANT:
Janssen Pharmaceutica, Inc.
Brian C. Anderson
Michael E. Stamp
1625 Eye Street, N.W.
Washinton, D.C. 20006
(202) 383-5300
COUNSEL FOR DEFENDANT/APPELLANT:
Janssen Pharmaceutica, Inc.
James Guglielmo
Guglielmo, Lopez, Tuttle, Hunter & Jarrell
Post Office Drawer 1329
306 East North Street
Opelousas, LA 70571-1299
(337) 948-8201
COUNSEL FOR DEFENDANT/APPELLANT:
Janssen Pharmaceutica, Inc.
PICKETT, Judge.
The plaintiff, Attorney General of the State of Louisiana, Charles C. Foti, Jr.,
moves to dismiss the devolutive appeal of the defendant, Janssen Pharmaceutica, Inc.,
as having been taken from a non-appealable, interlocutory judgment. For the reasons
assigned, we grant the motion to dismiss appeal, and we convert the appeal into an
application for supervisory writs.
This case arises out of the defendant’s manufacturing, marketing and sale of an
anti-psychotic drug called Risperdal. The plaintiff filed suit alleging that the
prescription Risperdal was not approved by the Food and Drug Administration for
pediatric use, although the defendant knowingly marketed and sold the drug for use
by children, causing the children severe injury and illness. The plaintiff further
alleged that the defendant marketed the drug for off-label adult use, causing injury
and illness. The plaintiff averred that the defendant continued engaging in unfair
trade practices, under Louisiana law, by promoting the off-label use of Risperdal for
pediatric and adult use.
The defendant filed a pleading styled a “Motion to Dismiss and Enjoin” with the
trial court, based on an allegedly unenforceable engagement letter between private
counsel and the Office of the Attorney General. The defendant moved to dismiss the
plaintiff’s original petition and first supplemental and amending petition. Further, the
defendant moved to enjoin the law firm of Morrow, Morrow, Ryan & Bassett, as
well as attorneys Kenneth W. DeJean, Patrick C. Morrow, James P. Ryan, Jeffrey M.
Bassett, Robert L. Salim, Kenneth T. Fibich and W. Michael Leebron, from
prosecuting this matter on behalf of the Office of the Louisiana Attorney General.
The aforementioned attorneys are the private counsel engaged by the Office of the
1
Attorney General to handle litigation regarding the prescriptions Zyprexa and
Risperdal.
On July 14, 2006, the trial court denied the defendant’s Motion to Dismiss and
Enjoin. Notice of the judgment was mailed on July 17, 2006. The defendant timely
filed a motion and order for devolutive appeal on July 20, 2006.
The record in this appeal was lodged in this court on September 6, 2006. The
instant Motion to Dismiss Appeal was filed October 16, 2006.
The defendant’s Motion to Dismiss and Enjoin is focused on dismissing and
enjoining the private counsel hired by the plaintiff. This judgment does not decide
the merits of this suit. A judgment which does not decide the merits of a case is an
interlocutory ruling. La.Code Civ.P. art. 1841. An interlocutory judgment is
appealable only when expressly provided by law. La.Code Civ.P. art. 2083. No law
expressly provides for an appeal of this judgment. Accordingly, we dismiss
appellant’s appeal at its cost. La.Code Civ.P. art. 2162.
The instant matter is properly considered under our supervisory jurisdiction. The
motion for devolutive appeal was filed within the time delays for seeking supervisory
relief. In the interest of justice, we hereby convert this appeal into a writ application
for consideration on the merits. The appellant has already filed its appellate brief.
The appellee is given until November 13, 2006, by which to file any opposition brief,
if desired.
MOTION TO DISMISS APPEAL GRANTED. APPEAL CONVERTED INTO
APPLICATION FOR SUPERVISORY WRIT.
2